<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000390320"><TermName>valrubicin</TermName><TermPronunciation>(val-ROO-bih-SIN)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat bladder cancer that does not respond to BCG (Bacillus Calmette Guerin). It is an anthracycline and is a type of antitumor antibiotic. Also called AD 32.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000713216" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;valrubicin&quot;" language="en" id="_3"/><MediaLink ref="CDR0000713215" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;valrubicina&quot;" language="es" id="_4"/><SpanishTermName>valrubicina</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar el cáncer de vejiga que no responde al BCG (Bacilo de Calmette Guérin). Es una antraciclina y un tipo de antibiótico antitumoral. También se llama AD 32.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2004-10-25</DateFirstPublished><DateLastModified>2007-06-19</DateLastModified></GlossaryTerm>
